TMO · 8-K · 20261021PR000173
Acquisitions and Divestitures
THERMO FISHER SCIENTIFIC INC. · 2026-10-21 · Importance 81 · Surprise 100
Thermo Fisher completed the previously announced divestiture of its microbiology business during the third quarter of 2026. Nine-month cash proceeds from the sale of a business, net of cash divested, were $1.021 billion. The company reported $8.877 billion of net cash used for acquisitions during the first nine months of 2026, compared with $4.037 billion in the prior-year period. Acquisitions and divestitures contributed 3 percentage points to third-quarter reported revenue growth.